有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | methyl 2-[2-[(2-fluorophenyl)methylsulfanyl]-6-oxo-1H-pyrimidin-4-yl]acetate | —— | C14H13FN2O3S |
|
—— | 1-[(2S)-1-ethylsulfonylpropan-2-yl]-1-methyl-3-[(1R,2R)-2-propylcyclohexyl]urea | —— | C16H32N2O3S |
|
—— | methyl 2-[2-(cyanomethylsulfanyl)-6-oxo-1H-pyrimidin-4-yl]acetate | —— | C9H9N3O3S |
|
—— | 6-(2-aminophenyl)-3-[(5-phenyl-1,3,4-oxadiazol-2-yl)methylsulfanyl]-4H-1,2,4-triazin-5-one | —— | C18H14N6O2S |
|
—— | 2-[(5-amino-1H-1,2,4-triazol-3-yl)sulfanyl]-N-cyclohexyl-N-[(4-fluorophenyl)methyl]acetamide | —— | C17H22FN5OS |
|
—— | 4-[[4-(2,4-dimethylphenyl)sulfanylanilino]methylidene]-5-(hydroxymethyl)-2-methylpyridin-3-one | —— | C22H22N2O2S |
|
—— | 4-[[2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]sulfanylethylamino]methylidene]-5-(hydroxymethyl)-2-methylpyridin-3-one | —— | C16H15ClF3N3O2S |
|
—— | N-[(1R)-1-(5-methyl-1,3,4-oxadiazol-2-yl)ethyl]-4-(trifluoromethylsulfanyl)aniline | —— | C12H12F3N3OS |
|
—— | N-[(1S)-1-(5-methyl-1,3,4-oxadiazol-2-yl)ethyl]-4-(trifluoromethylsulfanyl)aniline | —— | C12H12F3N3OS |
|
—— | ethyl (2Z)-2-[4-oxo-3-[2-[(6-oxo-4-propyl-1H-pyrimidin-2-yl)sulfanyl]ethyl]-1,3-thiazolidin-2-ylidene]acetate | —— | C16H21N3O4S2 |
|
—— | 1-methyl-3-[(1S)-1-(4-methylsulfanylphenyl)ethyl]-1-[(2R)-1-methylsulfonylpropan-2-yl]urea | —— | C15H24N2O3S2 |
|
—— | 1-methyl-3-[(1R)-1-(4-methylsulfanylphenyl)ethyl]-1-[(2R)-1-methylsulfonylpropan-2-yl]urea | —— | C15H24N2O3S2 |
|
—— | 1-methyl-3-[(1R)-1-(4-methylsulfanylphenyl)ethyl]-1-[(2S)-1-methylsulfonylpropan-2-yl]urea | —— | C15H24N2O3S2 |
|
—— | 1-methyl-3-[(1S)-1-(4-methylsulfanylphenyl)ethyl]-1-[(2S)-1-methylsulfonylpropan-2-yl]urea | —— | C15H24N2O3S2 |
|
—— | 4-[[5-(3-Methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]butan-2-one | —— | C13H15N3OS2 |
|
—— | N-[(3R)-3-cyanothiolan-3-yl]-3-(2,5-difluorophenyl)sulfanylpropanamide | —— | C14H14F2N2OS2 |
|
—— | N-[(3S)-3-cyanothiolan-3-yl]-3-(2,5-difluorophenyl)sulfanylpropanamide | —— | C14H14F2N2OS2 |
|
—— | 3-(2,5-difluorophenyl)sulfanyl-N-ethyl-N-[[(3R)-oxolan-3-yl]methyl]propanamide | —— | C16H21F2NO2S |
|
—— | 3-(2,5-difluorophenyl)sulfanyl-N-ethyl-N-[[(3S)-oxolan-3-yl]methyl]propanamide | —— | C16H21F2NO2S |
|
—— | (2R)-2-[4-[2-(4-bromophenyl)sulfanylacetyl]piperazin-1-yl]-3-methylbutanenitrile | —— | C17H22BrN3OS |
|
—— | 2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(2-cyanoethyl)acetamide | —— | C13H11BrN4O2S |
|
—— | 2-(4-chlorophenyl)sulfanyl-N-(1-cyanocyclopentyl)acetamide | —— | C14H15ClN2OS |
|
—— | (2S)-2-[4-[2-(4-bromophenyl)sulfanylacetyl]piperazin-1-yl]-3-methylbutanenitrile | —— | C17H22BrN3OS |
|
—— | (2S)-2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C11H10BrN3O2S |
|
—— | N,N-bis(2-cyanoethyl)-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]acetamide | —— | C12H14N4OS2 |
|
—— | 4-amino-3-[(1S)-cyclohex-2-en-1-yl]sulfanyl-6-methyl-1,2,4-triazin-5-one | —— | C10H14N4OS |
|
—— | 4-amino-3-[(1R)-cyclohex-2-en-1-yl]sulfanyl-6-methyl-1,2,4-triazin-5-one | —— | C10H14N4OS |
|
—— | (2R)-2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanenitrile | —— | C11H8BrN3OS |
|
—— | N-[(1S)-1-cyano-1-cyclopropylethyl]-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]acetamide | —— | C12H15N3OS2 |
|
—— | Tert-butyl 2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetate | —— | C14H15BrN2O3S |
|
—— | 2-Benzylsulfanyl-5-(2-bromophenyl)-1,3,4-oxadiazole | —— | C15H11BrN2OS |
|
—— | 2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(1R)-1-cyano-1-cyclopropylethyl]acetamide | —— | C16H15BrN4O2S |
|
—— | (2S)-N-[2-(1-methylimidazol-2-yl)sulfanylphenyl]-2-(1,3,5-trimethylpyrazol-4-yl)propanamide | —— | C19H23N5OS |
|
—— | (2R)-N-[2-(1-methylimidazol-2-yl)sulfanylphenyl]-2-(1,3,5-trimethylpyrazol-4-yl)propanamide | —— | C19H23N5OS |
|
—— | 1-[(3R)-3-(furan-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]ethanone | —— | C20H19N3O2S2 |
|
—— | 2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(2-cyanoethyl)-N-methylacetamide | —— | C14H13BrN4O2S |
|
—— | (2S)-2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(methylcarbamoyl)propanamide | —— | C13H13BrN4O3S |
|
—— | N-[(1R,2R,3R)-2,3-dimethylcyclohexyl]-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]acetamide | —— | C14H22N2OS2 |
|
—— | 2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]-N-propan-2-ylacetamide | —— | C9H14N2OS2 |
|
—— | (2S)-N-(furan-2-ylmethyl)-2-(1,3,4-thiadiazol-2-ylsulfanyl)propanamide | —— | C10H11N3O2S2 |
|
—— | 1-[(3R)-5-(4-chlorophenyl)-3-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-(1,3,4-thiadiazol-2-ylsulfanyl)ethanone | —— | C17H13ClN4O2S2 |
|
—— | (2R)-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]propanamide | —— | C7H10N2OS2 |
|
—— | 2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]-N-[(2S)-4-phenylbutan-2-yl]acetamide | —— | C16H20N2OS2 |
|
—— | [(1S)-1-[5-[(4-fluorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-2-methylpropyl]azanium | —— | C13H17FN3OS+ |
|
—— | (2R)-N-[(2-cyclopentyloxypyridin-3-yl)methyl]-2,3-dihydro-1,4-benzoxathiine-2-carboxamide | —— | C20H22N2O3S |
|
—— | (2S)-N-[(2-cyclopentyloxypyridin-3-yl)methyl]-2,3-dihydro-1,4-benzoxathiine-2-carboxamide | —— | C20H22N2O3S |
|
—— | (2R)-N-[[4-(4-fluorophenyl)oxan-4-yl]methyl]-2,3-dihydro-1,4-benzoxathiine-2-carboxamide | —— | C21H22FNO3S |
|
—— | (2S)-N-[[4-(4-fluorophenyl)oxan-4-yl]methyl]-2,3-dihydro-1,4-benzoxathiine-2-carboxamide | —— | C21H22FNO3S |
|
—— | 1-[(9aS)-1,3,4,5,7,8,9,9a-octahydropyrrolo[1,2-a][1,4]diazepin-2-yl]-3-(2-bromophenyl)sulfanylpropan-1-one | —— | C17H23BrN2OS |
|
—— | 1-[(9aR)-1,3,4,5,7,8,9,9a-octahydropyrrolo[1,2-a][1,4]diazepin-2-yl]-3-(2-bromophenyl)sulfanylpropan-1-one | —— | C17H23BrN2OS |
|